MSN: UC, UC Health launching clinical trial to study effectiveness of COVID-19 vaccine
Vaccine uses a genetic code to produce proteins that may generate protective antibodies
UC and UC Health are hosting a Phase 3 clinical trial to evaluate the effectiveness of a vaccine for COVID-19. UC is one of 90 sites across the United States selected for the study, which will administer the vaccine to volunteer participants and monitor its efficacy in eliciting an immune response that provides protection from COVID-19. The study is led by Carl Fichtenbaum, MD, and Maggie Powers-Fletcher, PhD, both of the UC College of Medicine Division of Infectious Diseases.
Other coverage:
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
UC study: Brain organ plays key role in adult neurogenesis
July 2, 2024
The University of Cincinnati has published research in the Proceedings of the National Academy of Sciences that found the choroid plexus and cerebrospinal fluid play a key role in maintaining a pool of newly born neurons to repair the adult brain after injury.
WalletHub: 5 best chip and pin credit cards
July 1, 2024
University of Cincinnati director discusses 5 best chip and pin credit cards with WalletHub
WVXU: Supreme Court temporarily blocks key air pollution...
July 1, 2024
University of Cincinnati law professor spoke with WVXU about recent Supreme Court decision to temporarily block key air pollution regulations.